Catalyst Investors Ask Chancery To Pause Asia Purchase Vote
Law 360
APRIL 7, 2023
Stockholders of biopharmaceutical company Catalyst Biosciences Inc. have asked the Delaware Chancery Court to halt a scheduled stockholder vote until the company releases more information about its planned acquisition of a fibrosis drug from an Asia-based drug development company.
40 
Let's personalize your content